3M™ Cavilon™ Advanced Skin Protectant has been shown to significantly improve severe cases of MASD (Moisture Associated Skin Damage). Cavilon advanced skin protectant creates a highly durable, ultra-thin, transparent barrier and doesn't require removal.
The ultra‑thin yet highly durable barrier is able to attach to wet, weepy surfaces and create a protective environment that repels irritants and supports healing, protecting patient's skin like never before.
Creates a protective environment that supports healing and helps reduce pain associated with IAD1
Application only needed two times per week
Attaches to wet, weepy damaged skin surfaces (i.e. superficial partial thickness skin loss)1
Allows easy, gentle cleansing with no removal required
3M™ Cavilon™ Advanced Skin Protectant has a formulation unlike any other skin protectant or moisture barrier currently available, allowing you to manage damaged skin or protect at-risk skin like never before. But what makes it so different from traditional skin protectants?
3M’s polymer forms a coating with the ability to elongate or conform, avoiding the cracking that can be common with other moisture barriers. This assures greater skin barrier integrity and durability and protection against challenging irritants, such as liquid stool and gastric fluids.
Unlike moisture barrier products that cannot reliably attach to underlying skin, 3M’s polymer-cyanoacrylate enables attachment to wet, weepy, damaged skin.¹ Once on the skin, 3M™ Cavilon™ Advanced Skin Protectant creates an environment that repels irritants and supports patient healing and comfort.
The polymer-cyanoacrylate system is delivered onto the skin by a non-stinging solvent in a single-use applicator that reduces the potential for cross-contamination. Plus, 3M™ Cavilon™ Advanced Skin Protectant doesn’t require removal, making wear easier for patients and easier for clinicians.
1. Brennan MR, Milne CT, Agrell-Kann M, Ekholm BP . Clinical evaluation of a barrier film for the management of incontinence associated dermatitis (IAD) in an open label, non-randomized, prospective study. Accepted for publication in Journal of Wound, Ostomy, and Continence Nursing (JWOCN).
2. 3M data on file. EM-05-013924.
3. Been R, Bernatchez SF, Conrad-Vlasak D, Asmus R, Eckholm B, P arks PJ. In vivo methods to evaluate a new skin protectant for loss of skin integrity. Accepted for publication in Wound Repair & Regeneration. DOI: 10.1111/wrr.12455 (http://onlinelibrary.wiley.com/doi/10.1111/wrr.12455/abstract)(in an animal model).
4. Brennan MR, Milne CT, Agrell-Kann M, Ekholm BP. Clinical evaluation of a barrier film for the management of incontinence associated dermatitis (IAD) in an open label, non-randomized, prospective study. Accepted for publication in Journal of Wound, Ostomy, and Continence Nursing (JWOCN). (n=9).
We have received your request. One of our 3M Health care experts will contact you shortly to arrange this for you.
An error has occurred while submitting. Please try again later...